Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
A M
AM
Westermann
D001859:Bone Neoplasms / Q000150:complications* / Q000556:secondary*; D001862:Bone Resorption; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D015994:Incidence; D007262:Infusions, Intravenous
D004164:Diphosphonates; D000077557:Ibandronic Acid